High-Revenue Products Used Off-Label May Draw Scrutiny – Ex-DoJ Lawyer
This article was originally published in The Gray Sheet
Executive Summary
Companies with high-ticket products being used off-label are more vulnerable to government enforcement actions for off-label promotional activities, according to Sonnenschein, Nath & Rosenthal partner T. Reed Stephens
You may also be interested in...
FDA Draft Attempts To Fill Gap From Expired Off-Label Distribution Reg
A draft 1guidance spelling out the circumstances under which manufacturers can distribute journal article reprints describing off-label uses of their products may offer a little more leeway, but it is not expected to have a major impact on oversight of marketing practices, industry lawyers say
FDA Draft Attempts To Fill Gap From Expired Off-Label Distribution Reg
A draft 1guidance spelling out the circumstances under which manufacturers can distribute journal article reprints describing off-label uses of their products may offer a little more leeway, but it is not expected to have a major impact on oversight of marketing practices, industry lawyers say
Off-Label Promotion Not Enough For Fed Intervention – Patton Boggs Lawyer
Promotion of off-label applications alone will rarely trigger a U.S. Department of Justice investigation of a drug or device manufacturer, according to Patton Boggs partner Laura Laemmle